231 related articles for article (PubMed ID: 15997234)
41. Why are antiepileptic drugs used for nonepileptic conditions?
Bialer M
Epilepsia; 2012 Dec; 53 Suppl 7():26-33. PubMed ID: 23153207
[TBL] [Abstract][Full Text] [Related]
42. Synergistic interaction between spinal gabapentin and oral B vitamins in a neuropathic pain model.
Reyes-García G; Medina-Santillán R; Rocha-González HI; Granados-Soto V
Proc West Pharmacol Soc; 2003; 46():91-4. PubMed ID: 14699897
[No Abstract] [Full Text] [Related]
43. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
Levi M; Yagen B; Bialer M
Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
[TBL] [Abstract][Full Text] [Related]
44. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue.
Shekh-Ahmad T; Bialer M; Yavin E
Epilepsy Res; 2012 Feb; 98(2-3):238-46. PubMed ID: 22057163
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
Bialer M; Kadry B; Abdul-Hai A; Haj-Yehia A; Sterling J; Herzig Y; Shirvan M
Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
[TBL] [Abstract][Full Text] [Related]
47. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
Shekh-Ahmad T; Mawasi H; McDonough JH; Yagen B; Bialer M
Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572
[TBL] [Abstract][Full Text] [Related]
48. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain.
Guneli E; Karabay Yavasoglu NU; Apaydin S; Uyar M; Uyar M
Pharmacol Biochem Behav; 2007 Nov; 88(1):9-17. PubMed ID: 17651791
[TBL] [Abstract][Full Text] [Related]
49. Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity.
Joshi SK; Hernandez G; Mikusa JP; Zhu CZ; Zhong C; Salyers A; Wismer CT; Chandran P; Decker MW; Honore P
Neuroscience; 2006 Dec; 143(2):587-96. PubMed ID: 16962719
[TBL] [Abstract][Full Text] [Related]
50. Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes.
Praena B; Bello-Morales R; de Castro F; López-Guerrero JA
Antiviral Res; 2019 Aug; 168():91-99. PubMed ID: 31132386
[TBL] [Abstract][Full Text] [Related]
51. [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].
Benjelloun G; Blandin K; Fossati P
Encephale; 2004; 30(4):400-3. PubMed ID: 15538315
[TBL] [Abstract][Full Text] [Related]
52. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain.
Park HJ; Lee Y; Lee J; Park C; Moon DE
Can J Anaesth; 2006 May; 53(5):470-7. PubMed ID: 16636031
[TBL] [Abstract][Full Text] [Related]
53. Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors.
Gutierrez VP; Konno K; Chacur M; Sampaio SC; Picolo G; Brigatte P; Zambelli VO; Cury Y
Eur J Pharmacol; 2008 Oct; 594(1-3):84-92. PubMed ID: 18703042
[TBL] [Abstract][Full Text] [Related]
54. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
Lee HG; Park SK; Yoon MH
Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
[TBL] [Abstract][Full Text] [Related]
55. Antinociceptive synergy between dexamethasone and the B vitamin complex in a neuropathic pain model in the rat.
Caram-Salas NL; Medina-Santillán R; Reyes-García G; Granados-Soto V
Proc West Pharmacol Soc; 2004; 47():88-91. PubMed ID: 15633621
[TBL] [Abstract][Full Text] [Related]
56. New generation of valproic acid.
Trojnar MK; Wierzchowska-Cioch E; Krzyzanowski M; Jargiełło M; Czuczwar SJ
Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
[TBL] [Abstract][Full Text] [Related]
57. Unity vs. diversity of neuropathic pain mechanisms: Allodynia and hyperalgesia in rats selected for heritable predisposition to spontaneous pain.
Ziv-Sefer S; Raber P; Barbash S; Devor M
Pain; 2009 Nov; 146(1-2):148-57. PubMed ID: 19683390
[TBL] [Abstract][Full Text] [Related]
58. Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Okada A; Aoki Y; Kushima K; Kurihara H; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs.
Haj-Yehia A; Bialer M
J Pharm Sci; 1988 Oct; 77(10):831-4. PubMed ID: 3148708
[TBL] [Abstract][Full Text] [Related]
60. Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase.
Kudin AP; Mawasi H; Eisenkraft A; Elger CE; Bialer M; Kunz WS
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28878165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
